The UC Gardner Neuroscience Institute has received $19 million in federal funding from the National Institutes of Health to serve as the lead center for a Phase 2 clinical trial that will study the efficacy of a new monoclonal antibody treatment for patients ineligible for currently available treatments.

Carl H. Lindner College of Business student Lance Entsuah, BA ’24, recently earned admission to the prestigious Schwarzman Scholars program that offers a one-year, fully funded master’s degree program in global affairs from Tsinghua University’s Schwarzman College in Beijing, China.